Research & Literature

Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.

Cesar B, Dwyer MG, Shucard JL, et al.

AJNR. American journal of neuroradiology 2015; (36(10)):1874-83 doi:10.3174/ajnr.A4354.

Successful Treatment of Lupus Cerebrovascular Disease with Mycophenolate Mofetil.

Higashioka K, Yoshida K, Oryoji K, et al.

Internal medicine (Tokyo, Japan) 2015; (54(17)):2255-9 doi:10.2169/internalmedicine.54.4582.

Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.

Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, et al.

The Journal of rheumatology 2015; (42(11)):2082-91 doi:10.3899/jrheum.150395.

B cells biology in systemic lupus erythematosus-from bench to bedside.

Zhao L, Ye Y, Zhang X

Science China. Life sciences 2015; (58(11)):1111-25 doi:10.1007/s11427-015-4953-x.

Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.

Lee YH, Choi SJ, Ji JD, Song GG

Lupus 2016; (25(7)):727-34 doi:10.1177/0961203315627202.

Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products.

Wallace DJ, Silverman SL, Conklin J, et al.

Lupus science & medicine 2016; (3(1)):e000127 doi:10.1136/lupus-2015-000127.

[Neurocognitive Disorders Caused by Central Nervous System Lupus Erythematosus].

Nishimura K

Brain and nerve = Shinkei kenkyu no shinpo 2016; (68(4)):365-73 doi:10.11477/mf.1416200406.

Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.

Narayanan K, Marwaha V, Shanmuganandan K, Shankar S

Medical journal, Armed Forces India 2010; (66(2)):102-7 doi:10.1016/S0377-1237(10)80118-2.

Treat to target in systemic lupus erythematosus: a commentary.

Ugarte-Gil MF, Burgos PI, Alarcón GS

Clinical rheumatology 2016; (35(8)):1903-1907 doi:10.1007/s10067-016-3346-2.

Human effector B lymphocytes express ARID3a and secrete interferon alpha.

Ward JM, Ratliff ML, Dozmorov MG, et al.

Journal of autoimmunity 2016; (75()):130-140 doi:10.1016/j.jaut.2016.08.003.

Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics, Disease Associations, Treatments, and Outcomes in a Series of 90 Patients at Mayo Clinic, 1996-2011.

Alniemi DT, Gutierrez A, Drage LA, Wetter DA

Mayo Clinic proceedings 2017; (92(3)):406-414 doi:10.1016/j.mayocp.2016.10.030.

What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.

Flechsig A, Rose T, Barkhudarova F, et al.

Clinical and experimental rheumatology 2017; (35(4)):598-606.

Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Yu F, Haas M, Glassock R, Zhao MH

Nature reviews. Nephrology 2017; (13(8)):483-495 doi:10.1038/nrneph.2017.85.

A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.

Satish S, Deka P, Shetty MS

Journal of laboratory physicians 2017; (9(3)):149-155 doi:10.4103/JLP.JLP_44_16.

The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project.

Dall'Era M, Cisternas MG, Snipes K, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2017; (69(10)):1996-2005 doi:10.1002/art.40191.

Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus.

Su F, Xiao W, Yang P, et al.

Anais brasileiros de dermatologia 2017; (92(4)):466-469 doi:10.1590/abd1806-4841.20175476.

Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.

İlgen U, Yayla ME, Ateş A, et al.

Lupus 2018; (27(4)):665-669 doi:10.1177/0961203317734924.

Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE.

Esteves GCX, Gormezano NWS, Pereira OL, et al.

Modern rheumatology 2018; (28(4)):649-653 doi:10.1080/14397595.2017.1386836.

Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?

Cunha C, Alexander S, Ashby D, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018; (33(9)):1604-1610 doi:10.1093/ndt/gfx318.

Long-term mortality and morbidity of patients with systemic lupus erythematosus: a single-center cohort study in China.

Wang Z, Li M, Wang Y, et al.

Lupus 2018; (27(5)):864-869 doi:10.1177/0961203317751852.

Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.

Liu S, Cheng Y, Zhao Y, et al.

Frontiers in psychiatry 2018; (9()):8 doi:10.3389/fpsyt.2018.00008.

Pediatric systemic lupus erythematosus. Retrospective analysis of clinico-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score.

Nazri SKSM, Wong KK, Hamid WZWA

Saudi medical journal 2018; (39(6)):627-631 doi:10.15537/smj.2018.6.22112.

[Analysis of 20-year survival rate and prognostic indicators of systemic lupus erythematosus].

Wang ZR, Ren LM, Li R, et al.

Zhonghua yi xue za zhi 2019; (99(3)):178-182 doi:10.3760/cma.j.issn.0376-2491.2019.03.005.

Lupus nephritis: A historical appraisal of how a skin lesion became a kidney disease
.

Airy M, Eknoyan G

Clinical nephrology 2019; (91(6)):325-333 doi:10.5414/CN109675.

Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.

Sun J, Li X, Zhou H, et al.

Journal of immunology research 2019; (2019()):7430780 doi:10.1155/2019/7430780.

Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus.

Heshin-Bekenstein M, Trupin L, Yelin E, et al.

Seminars in arthritis and rheumatism 2019; (49(2)):267-272 doi:10.1016/j.semarthrit.2019.05.010.

Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.

Zhang L, Geng S, Qian L, et al.

International journal of clinical pharmacy 2019; (41(5)):1247-1255 doi:10.1007/s11096-019-00870-y.

Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Wang X, Xia Y

Frontiers in immunology 2019; (10()):1667 doi:10.3389/fimmu.2019.01667.

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Aringer M, Costenbader K, Daikh D, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(9)):1400-1412 doi:10.1002/art.40930.

The clinical characteristics of systemic lupus erythematosus patients in Indonesia: a cohort registry from an Indonesia-based tertiary referral hospital.

Hamijoyo L, Candrianita S, Rahmadi AR, et al.

Lupus 2019; (28(13)):1604-1609 doi:10.1177/0961203319878499.

Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.

Navarro D, Ferreira AC, Viana H, et al.

Acta medica portuguesa 2019; (32(10)):635-640 doi:10.20344/amp.11598.

Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options.

Smith EMD, Lythgoe H, Midgley A, et al.

Clinical immunology (Orlando, Fla.) 2019; (209()):108274 doi:10.1016/j.clim.2019.108274.

EULAR/ACR classification criteria for SLE.

Aringer M

Seminars in arthritis and rheumatism 2019; (49(3S)):S14-S17 doi:10.1016/j.semarthrit.2019.09.009.

[Case of a Сombination of Lupus Erythematosus, Antiphospholipid Syndrome and Myocardial Infarction].

Kosheleva NA, Nikitina NM, Andreeva EU

Kardiologiia 2019; (59(12)):92-96 doi:10.18087/cardio.2019.12.n610.

Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.

Rogers JL, Eudy AM, Pisetsky D, et al.

Arthritis care & research 2021; (73(3)):386-393 doi:10.1002/acr.24135.

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.

Fanouriakis A, Kostopoulou M, Cheema K, et al.

Annals of the rheumatic diseases 2020; (79(6)):713-723 doi:10.1136/annrheumdis-2020-216924.

A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China.

Tao J, Wang H, Yu XJ, et al.

American journal of nephrology 2020; (51(6)):483-492 doi:10.1159/000507213.

Anti-Smith Antibody Positivity Without Lupus in the Setting of Lung Cancer.

Timlin H, Machireddy K, Shiroky J, et al.

Cureus 2020; (12(5)):e8298 doi:10.7759/cureus.8298.

Ciprofloxacin-Induced Reaction Imitating a Lupus Flare: A Case Report.

Liaqat A, Barlas A, Barlas T, et al.

Cureus 2020; (12(5)):e8327 doi:10.7759/cureus.8327.

Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus.

Stec-Polak M, Matyja-Bednarczyk A, Wojas-Pelc A, Pastuszczak M

Clinical and experimental rheumatology 2021; (39(5)):955-960 doi:10.55563/clinexprheumatol/syxbuz.

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy.

Tonsawan P, Sawanyawisuth K

Auto- immunity highlights 2020; (11(1)):18 doi:10.1186/s13317-020-00140-2.

New lupus criteria: a critical view.

Aringer M, Johnson SR

Current opinion in rheumatology 2021; (33(2)):205-210 doi:10.1097/BOR.0000000000000771.

Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort.

Kernder A, Richter JG, Fischer-Betz R, et al.

Lupus 2021; (30(3)):431-438 doi:10.1177/0961203320983445.

"Protenuria in SLE: Is it always lupus?"

Celia AI, Priori R, Cerbelli B, et al.

Lupus 2021; (30(4)):664-668 doi:10.1177/0961203320983458.

Orofacial manifestations of rheumatoid arthritis and systemic lupus erythematosus: a narrative review.

Thomas DC, Kohli D, Chen N, et al.

Quintessence international (Berlin, Germany : 1985) 2021; (52(5)):454-466 doi:10.3290/j.qi.b1043985.

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus.

Abdelbaky MSE, El Mamoun TA, Mabrouk FI, Hassan RM

The Egyptian journal of internal medicine 2021; (33(1)):18 doi:10.1186/s43162-021-00047-y.

Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus.

Correa-Rodríguez M, Pocovi-Gerardino G, Callejas-Rubio JL, et al.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2021; (69(8)):1417-1425 doi:10.1136/jim-2021-001887.

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.

Drosos GC, Vedder D, Houben E, et al.

Annals of the rheumatic diseases 2022; (81(6)):768-779 doi:10.1136/annrheumdis-2021-221733.

The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous.

Woo JMP, Parks CG, Jacobsen S, et al.

Journal of internal medicine 2022; (291(6)):755-778 doi:10.1111/joim.13448.

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.

Tanaka S, Kawaguchi T, Kudo R, et al.

Internal medicine (Tokyo, Japan) 2022; (61(20)):3131-3135 doi:10.2169/internalmedicine.9123-21.

A One-Year-Old Girl With Human Parvovirus B19 Infection and Hypocomplementemia Mimicking Incomplete Kawasaki Disease.

Oura K, Ishikawa S, Shiraishi H, et al.

Journal of medical cases 2022; (13(5)):229-234 doi:10.14740/jmc3917.

Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus.

Samões B, Zen M, Abelha-Aleixo J, et al.

Autoimmunity reviews 2022; (21(10)):103165 doi:10.1016/j.autrev.2022.103165.

A Review of Lupus Nephritis.

Alforaih N, Whittall-Garcia L, Touma Z

The journal of applied laboratory medicine 2022; (7(6)):1450-1467 doi:10.1093/jalm/jfac036.

Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study.

Gamal SM, Fouad N, Yosry N, et al.

Archives of rheumatology 2022; (37(2)):280-287 doi:10.46497/ArchRheumatol.2022.8888.

Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.

Mertz P, Piga M, Chessa E, et al.

RMD open 2022; (8(2)) doi:10.1136/rmdopen-2022-002395.

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study.

Pappa M, Kosmetatou M, Elezoglou A, et al.

Mediterranean journal of rheumatology 2022; (33(2)):263-267 doi:10.31138/mjr.33.2.263.

An Uncommon Correlation of Rheumatoid Arthritis and Lupus Nephritis: A Case Report on the Unusual Progression of Lupus Nephritis.

Lam LC, Yadav VD, Mihal VJ

Cureus 2022; (14(8)):e27620 doi:10.7759/cureus.27620.

Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study.

Tian J, Zhang D, Yao X, et al.

Annals of the rheumatic diseases 2023; (82(3)):351-356 doi:10.1136/ard-2022-223035.

Evaluating the Threshold Score for Classification of Systemic Lupus Erythematosus Using the EULAR/ACR Criteria.

Johnson SR, Diaz Martinez JP, Whittall-Garcia L, et al.

The Journal of rheumatology 2023; (50(4)):512-518 doi:10.3899/jrheum.220100.

Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus.

Chandler MT, Santacroce LM, Costenbader KH, et al.

Seminars in arthritis and rheumatism 2023; (58()):152122 doi:10.1016/j.semarthrit.2022.152122.

Psychological Implications to the Therapy of Systemic Lupus Erythematosus.

Warchoł-Biedermann K, Mojs E, Sikorska D, et al.

International journal of environmental research and public health 2022; (19(23)) doi:10.3390/ijerph192316021.

Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico.

González-Meléndez A, Báez-Negrón L, Ríos-Rivera R, et al.

Lupus 2023; (32(4)):571-579 doi:10.1177/09612033231151898.

Antibodies against type I IFN: The bad guys self-restrain in systemic lupus erythematosus.

Fillatreau S

Cell reports. Medicine 2023; (4(1)):100903 doi:10.1016/j.xcrm.2022.100903.

Jaccoud's Arthropathy in a Case of Mixed Connective Tissue Disorder: An Interesting Tale.

Bhagawati J, Patel M, Saboo K, et al.

Cureus 2022; (14(12)):e33170 doi:10.7759/cureus.33170.

Belimumab for the treatment of pediatric patients with lupus nephritis.

Stohl W, Kwok A

Expert opinion on biological therapy 2023; (23(3)):243-251 doi:10.1080/14712598.2023.2178297.

A Rare Case of Systemic Lupus Erythematosus With Diffuse Alveolar Hemorrhage and Guillain-Barre Syndrome.

Althagafi ZA, Al-Bishi SS, Ansari R, et al.

Cureus 2023; (15(1)):e33984 doi:10.7759/cureus.33984.

Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.

Foulke G, Helm LA, Clebak KT, Helm M

FP essentials 2023; (526()):25-36.

T-bet-expressing B cells contribute to the autoreactive plasma cell pool in Lyn-/- mice.

Ottens K, Schneider J, Satterthwaite AB

European journal of immunology 2023; (53(8)):e2250300 doi:10.1002/eji.202250300.

Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.

Katayama Y, Yanai R, Itaya T, et al.

Clinical rheumatology 2023; (42(11)):2931-2941 doi:10.1007/s10067-023-06608-6.

Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis.

Shin JM, Kim D, Kwon YC, et al.

Journal of rheumatic diseases 2021; (28(3)):150-158 doi:10.4078/jrd.2021.28.3.150.

Transient Systemic Lupus Erythematosus-like Syndrome Associated With Parvovirus B19 Infection: A Case Report.

Kim MY, Lee JJ

Journal of rheumatic diseases 2021; (28(1)):45-49 doi:10.4078/jrd.2021.28.1.45.

Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients at a Tertiary Hospital in Peru.

Camones-Huerta J, Arias-Osorio C, Rodriguez-Hurtado D, Aguilar-Olano J

European journal of rheumatology 2023; (10(4)):143-147 doi:10.5152/eurjrheum.2023.22095.

Disease-modifying effect and long-term safety of belimumab in patients with systemic lupus erythematosus: A single-center retrospective study.

Nakai T, Fukui S, Sawada H, et al.

Lupus 2023; (32(13)):1518-1527 doi:10.1177/09612033231208845.

The Discrepancy of ANA and Compartment Bead Patterns Suggestive of a Neuropsychiatry Systemic Lupus Erythematosus (NPSLE).

Fitriah M, Rahmawati LD, Wulanda IA, et al.

Case reports in psychiatry 2023; (2023()):5260208 doi:10.1155/2023/5260208.

An Atypical Initial Manifestation of Systemic Lupus Erythematosus: Lupus Enteritis Accompanied by Intestinal Pseudo-Obstruction and Bilateral Hydronephroureter.

Naeem F, Noor MU, Batool S, et al.

Cureus 2023; (15(12)):e50628 doi:10.7759/cureus.50628.

Dermatologists' and Rheumatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study.

Alghamdi AS, AlQefari GB, Alduraibi K, et al.

Cureus 2024; (16(3)):e56179 doi:10.7759/cureus.56179.

Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus.

Brahmanti H, Wahono CS, Pratama MZ, et al.

Mediterranean journal of rheumatology 2024; (35(1)):143-149 doi:10.31138/mjr.200423.aos.

Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review.

Rice-Canetto TE, Joshi SJ, Kyan KA, Siddiqi J

Cureus 2024; (16(6)):e61678 doi:10.7759/cureus.61678.

Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review.

Shantz E, Elliott SJ, Sperling C, et al.

Lupus science & medicine 2024; (11(2)) doi:10.1136/lupus-2024-001155.

Revisiting Childhood-Onset Systemic Lupus Erythematosus.

Avar-Aydın PÖ, Brunner HI

Turkish archives of pediatrics 2024; (59(4)):336-344 doi:10.5152/TurkArchPediatr.2024.24097.

Addressing the research gap: access to care hinders genetic discovery in systemic lupus erythematosus patients throughout the African diaspora.

Hwang J, Dzifa Dey I, Ayanlowo O, et al.

Frontiers in genetics 2024; (15()):1414490 doi:10.3389/fgene.2024.1414490.

Relationship between clinical manifestations and serological profile in patients affected by Systemic Lupus Erythematosus.

Nicola S, Borrelli R, Corradi F, et al.

Frontiers in immunology 2024; (15()):1390642 doi:10.3389/fimmu.2024.1390642.

Central neurological manifestations in a sample of Syrian patients with systemic lupus erythematosus: cross-sectional study.

Kudsi M, Achmeh B, Khalayli N, et al.

Annals of medicine and surgery (2012) 2024; (86(9)):5096-5100 doi:10.1097/MS9.0000000000002361.

Improving lupus care index documentation in patients with childhood-onset systemic lupus erythematosus.

Barbar-Smiley FA, Yildirim-Toruner C, Akoghlanian S, et al.

Frontiers in pediatrics 2024; (12()):1428644 doi:10.3389/fped.2024.1428644.

Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull's Eye Maculopathy.

Snow Z, Seely K, Barrett S, et al.

Current ophthalmology reports 2024; (12(3)):38-48 doi:10.1007/s40135-024-00321-6.

Organ-based characterization of B cells in patients with systemic lupus erythematosus.

Wang Y, Zhao R, Liang Q, et al.

Frontiers in immunology 2025; (16()):1509033 doi:10.3389/fimmu.2025.1509033.

Fragmented care in lupus: Patient experiences and insights.

Bam A

African journal of disability 2025; (14()):1562 doi:10.4102/ajod.v14i0.1562.

Guillain-Barré Syndrome as the Initial Presentation of Systemic Lupus Erythematosus: A Case Report.

Sharma RR, Ghimire P, Devkota N, et al.

Clinical case reports 2025; (13(2)):e70223 doi:10.1002/ccr3.70223.

The unique challenges of childhood-onset systemic lupus erythematosus and lupus nephritis patients: a proposed framework for an individualized transitional care plan.

Renson T, Lightstone L, Ciurtin C, et al.

Pediatric nephrology (Berlin, Germany) 2025; (40(10)):3045-3053 doi:10.1007/s00467-024-06654-5.

Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus.

Wang Y, Guo S, Shi Y, et al.

Clinical rheumatology 2025; (44(5)):1927-1937 doi:10.1007/s10067-025-07413-z.

Prevention and detection of hydroxychloroquine-induced retinopathy in patients with systemic autoimmune diseases.

Kim KE, Ahn SJ

Expert opinion on drug safety 2026; (25(1)):9-21 doi:10.1080/14740338.2025.2544044.

Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus.

Liu X, Wang C, Guan X

Journal of autoimmunity 2025; (157()):103488 doi:10.1016/j.jaut.2025.103488.

Juvenile systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome: a case report and literature review.

Luo M, He H, Zhou Q, et al.

Orphanet journal of rare diseases 2025; (20(1)):566 doi:10.1186/s13023-025-04044-0.

Clinicopathological correlation in lupus nephritis: a 5-year tertiary center experience using International Society of Nephrology/Renal Pathology Society classification.

Rangachari B, Sasidharannair Chandrakumari A, Rao L, et al.

Annals of medicine and surgery (2012) 2026; (88(3)):2282-2287 doi:10.1097/MS9.0000000000004787.